Clinical Trials Browser

Camurati-Engelmann Syndrome × Lymphoid × Clear all

NCT06487624 2026-04-13

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

Phase 1 Recruiting

Camurati-Engelmann Syndrome, Hodgkin Disease, Neoplasms